Reata Pharmaceuticals, Inc. and Blackstone Life Sciences Announce $350 Million Strategic InvestmentGlobeNewsWire • 06/11/20
Why Is Reata Pharmaceuticals, Inc. (RETA) Down 19.8% Since Last Earnings Report?Zacks Investment Research • 06/10/20
Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20
Reata Pharmaceuticals Inc (RETA) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/11/20
Reata Pharmaceuticals Provides Update on the Impact of the COVID-19 Pandemic on Its Clinical Studies and Business OperationsGlobeNewsWire • 03/30/20
Reata Pharmaceuticals, Inc. (RETA) Down 37.8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/20/20
Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/20/20
Reata Pharmaceuticals Just Raised $505 Million to Treat Orphan Diseases: What it Means for InvestorsThe Motley Fool • 11/26/19
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewsWire • 11/18/19
Reata Pharmaceuticals, Inc. Announces Pricing of Upsized Class A Common Stock Public OfferingGlobeNewsWire • 11/14/19
Reata Pharmaceuticals (RETA) CEO Warren Huff Discusses Positive Topline Pivotal Year 1 CARDINAL Data (Transcript)Seeking Alpha • 11/13/19
This Biotech Has Rocketed 181% Since October — Did It Just Tap Out?Investors Business Daily • 11/11/19